Work

Abstract 4473: Advancing new rational drug combinations to treat mutant KRAS-driven pancreatic adenocarcinoma.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-4473

Authors: Brajendra K. Tripathi, Sophia M. Shahin, Elise Van Meter, Marian E. Durkin, Xiaolan Qian, Ross Lake, James H. Doroshow, Dunrui Wang, Douglas R. Lowy

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148681268

Cites:

Cited by:

Related to: